This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have downgraded several stocks, including Blackstone Inc., Virpax Pharmaceuticals, Daqo New Energy Corp., and FactSet Research Systems. These downgrades reflect a shift in analyst sentiment, potentially impacting short-term stock performance.
October 09, 2024 | 4:21 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Daiwa Capital downgraded Daqo New Energy from Outperform to Hold, but raised the price target from $18 to $25. The stock closed at $20.94.
While the downgrade to Hold suggests caution, the raised price target indicates some positive outlook, resulting in a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Piper Sandler downgraded Blackstone Inc. from Overweight to Neutral, maintaining a price target of $149. The stock closed at $49.44.
The downgrade from Overweight to Neutral by Piper Sandler suggests a less optimistic outlook, which could lead to a short-term decline in Blackstone's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Redburn Atlantic downgraded FactSet Research Systems from Neutral to Sell, lowering the price target from $420 to $380. The stock closed at $456.83.
The downgrade to Sell and reduced price target suggest a negative outlook, likely leading to a short-term decline in FactSet's stock price.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Maxim Group downgraded Virpax Pharmaceuticals from Buy to Hold. The stock closed at $0.4810.
The downgrade from Buy to Hold indicates a reduced growth expectation, likely leading to a short-term negative impact on Virpax's stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100